MENU

NAYA Stock NAYA Biosciences (NAYA, $0.32) Stochastic Oscillator left the oversold zone on March 04, 2025

A.I.dvisor
at Tickeron.com
Loading...
NAYA - NAYA Biosciences Inc
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $0.32
Daily change: -$0.051 (-13.75%)
Daily volume: 130.5K
Capitalization: $1.4M
Industry: Medical Specialties
This is a signal that NAYA's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 59 similar cases where NAYA's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

NAYA's RSI Oscillator descending into oversold zone

The RSI Oscillator for NAYA moved into overbought territory on March 04, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NAYA advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

NAYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NAYA as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NAYA entered a downward trend on February 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.752) is normal, around the industry mean (23.546). P/E Ratio (0.054) is within average values for comparable stocks, (82.440). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.494) is also within normal values, averaging (41.434).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NAYA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
5582 Broadcast Court
Phone
+1 978 878-9505
Employees
16
Web
https://www.invobio.com